Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Exanthema × Loperamide × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 11 Diarrhea 5 Rectal Neoplasms 3 Sarcoma, Alveolar Soft Part 2 Ovarian Neoplasms 2 Vulvar Neoplasms 1 Vulvar Diseases 1 Uterine Neoplasms 1 Uterine Cervical Neoplasms 1 Uterine Cervical Dysplasia 1 Urogenital Neoplasms 1 Triple Negative Breast Neoplasms 1 Short Bowel Syndrome 1 Recurrence 1 Papillomavirus Infections 1 Neoplasms 1 Melanoma 1 Lung Neoplasms 1 Low Anterior Resection Syndrome 1 Gliosarcoma 1 Glioblastoma 1 Exanthema 1 Esophageal Squamous Cell Carcinoma 1 Endometrial Neoplasms 1 Colorectal Neoplasms 1 Colorectal Cancer Metastatic 1 Colonic Neoplasms 1 Colitis, Ulcerative 1 Colitis 1 Chondrosarcoma 1

Interventions

Gels 2 Fulvestrant 2 Doxycycline 2 Dapsone 2 ruxolitinib 1 dexpanthenol 1 ceterizine hydrochloride 1 capivasertib 1 benralizumab 1 Sirolimus 1 Provitamins 1 Prednisone 1 Panitumumab 1 Loperamide 1 Irinotecan 1 IFL protocol 1 Cetuximab 1 Anti-Bacterial Agents 1 Alpelisib 1 Acitretin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07426822 2026-02-24

SAFE-CAP

Yale University

Phase 2 Not yet recruiting

Diarrhea, Exanthema

Data powered by HemOnc (CC BY 4.0) Colophon ⚡